Targeting BCL2 with BH3 mimetics: Basic Science and Clinical Application of Venetoclax in CLL and related B cell malignancies.
This article is protected by copyright. All rights reserved.
PMID: 27806433 [PubMed - as supplied by publisher]
Source: Clinical Pharmacology and Therapeutics - Category: Drugs & Pharmacology Authors: Roberts AW, Huang DC Tags: Clin Pharmacol Ther Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Chronic Leukemia | Chronic Lymphocytic Leukemia | Drugs & Pharmacology | Leukemia | Lymphoma | Science